Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Ann Clin Transl Neurol. 2024 May;11(5):1359-1364. doi: 10.1002/acn3.52053. Epub 2024 Apr 1.
Neuroferritinopathy is a disorder of neurodegeneration with brain iron accumulation that has no proven disease-modifying treatments. Clinical trials require biomarkers of iron deposition. We examined brain iron accumulation in one presymptomatic FTL mutation carrier, two individuals with neuroferritinopathy and one healthy control using ultra-high-field 7T MRI. There was increased magnetic susceptibility, suggestive of iron deposition, in superficial and deep gray matter in both presymptomatic and symptomatic neuroferritinopathy. Cavitation of the putamen and globus pallidus increased with disease stage and at follow up. The widespread brain iron deposition in presymptomatic and early disease provides an opportunity for monitoring disease-modifying intervention.
神经铁粒蛋白病是一种伴有脑铁蓄积的神经退行性疾病,目前尚无明确的疾病修饰治疗方法。临床试验需要铁沉积的生物标志物。我们使用超高场 7T MRI 检查了一位无症状 FTL 突变携带者、两位神经铁粒蛋白病患者和一位健康对照者的脑铁蓄积情况。在无症状和有症状的神经铁粒蛋白病患者的浅灰质和深灰质中均发现了增加的磁化率,提示铁沉积。壳核和苍白球的空洞化随着疾病阶段和随访而增加。在无症状和早期疾病中广泛的脑铁沉积为监测疾病修饰干预提供了机会。